Model
Edge
Lineage Cell Therapeutics
0001509725
Filing Type
4
Filing Date
3/24/2022
Updated
3/25/22, 10:15 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership